Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
36.4M
-
Shares change
-
-1.58M
-
Total reported value, excl. options
-
$719M
-
Value change
-
-$39M
-
Number of buys
-
67
-
Number of sells
-
-79
-
Price
-
$19.74
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q3 2021
177 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q3 2021.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.4M shares
.
Largest 10 shareholders include BlackRock Inc. (5.63M shares), JANUS HENDERSON GROUP PLC (4.1M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.63M shares), Rubric Capital Management LP (2.61M shares), VANGUARD GROUP INC (2.34M shares), Camber Capital Management LP (2M shares), RENAISSANCE TECHNOLOGIES LLC (1.3M shares), STATE STREET CORP (1.15M shares), PRINCIPAL FINANCIAL GROUP INC (1.06M shares), and Invesco Ltd. (961K shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.